Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marla Gearing

Showing results (171-180 of 190) with videos related to

Pageof 19
Sort By:
Medrxiv : the Preprint Server for Health Sciences|March 11, 2024
Association of Structural Forms of 17q21.31 with the Risk of Progressive Supranuclear Palsy and <i>MAPT</i> Sub-haplotypesHui Wang, Timothy S Chang, Beth A Dombroski, et al.
Acta Neuropathologica|January 21, 2014
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansionsMichael D Gallagher, Eunran Suh, Murray Grossman, et al.
Human Molecular Genetics|May 5, 2012
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseasesGiovanni Coppola, Subashchandrabose Chinnathambi, Jason JiYong Lee, et al.
Acta Neuropathologica|November 1, 2021
Genome-wide association study and functional validation implicates JADE1 in tauopathyKurt Farrell, SoongHo Kim, Natalia Han, et al.
Acta Neuropathologica|February 11, 2019
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLDCyril Pottier, Yingxue Ren, Ralph B Perkerson, et al.
Nature Genetics|February 16, 2010
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusionsVivianna M Van Deerlin, Patrick M A Sleiman, Maria Martinez-Lage, et al.
Nature Communications|April 25, 2025
Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencingCyril Pottier, Fahri Küçükali, Matt Baker, et al.
The Lancet. Neurology|May 5, 2018
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association studyCyril Pottier, Xiaolai Zhou, Ralph B Perkerson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome SequencingCyril Pottier, Fahri Küçükali, Matt Baker, et al.
Nature Genetics|March 13, 2026
A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusionsWouter De Coster, Marleen Van den Broeck, Matt Baker, et al.
Pageof 19

Showing results (171-180 of 190) with videos related to

Sort By:
Pageof 19
Medrxiv : the Preprint Server for Health Sciences|March 11, 2024
Association of Structural Forms of 17q21.31 with the Risk of Progressive Supranuclear Palsy and <i>MAPT</i> Sub-haplotypesHui Wang, Timothy S Chang, Beth A Dombroski, et al.
Acta Neuropathologica|January 21, 2014
TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansionsMichael D Gallagher, Eunran Suh, Murray Grossman, et al.
Human Molecular Genetics|May 5, 2012
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseasesGiovanni Coppola, Subashchandrabose Chinnathambi, Jason JiYong Lee, et al.
Acta Neuropathologica|November 1, 2021
Genome-wide association study and functional validation implicates JADE1 in tauopathyKurt Farrell, SoongHo Kim, Natalia Han, et al.
Acta Neuropathologica|February 11, 2019
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLDCyril Pottier, Yingxue Ren, Ralph B Perkerson, et al.
Nature Genetics|February 16, 2010
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusionsVivianna M Van Deerlin, Patrick M A Sleiman, Maria Martinez-Lage, et al.
Nature Communications|April 25, 2025
Deciphering distinct genetic risk factors for FTLD-TDP pathological subtypes via whole-genome sequencingCyril Pottier, Fahri Küçükali, Matt Baker, et al.
The Lancet. Neurology|May 5, 2018
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association studyCyril Pottier, Xiaolai Zhou, Ralph B Perkerson, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2024
Deciphering Distinct Genetic Risk Factors for FTLD-TDP Pathological Subtypes via Whole-Genome SequencingCyril Pottier, Fahri Küçükali, Matt Baker, et al.
Nature Genetics|March 13, 2026
A repeat expansion in GOLGA8A is a major risk factor for atypical frontotemporal lobar degeneration with ubiquitin-positive inclusionsWouter De Coster, Marleen Van den Broeck, Matt Baker, et al.
Pageof 19